ClinicalTrials.gov
public full text
Public Domain
Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
The purpose of the study is to determine whether gene therapy is safe and effective for the treatment of severe childhood blindness caused by mutations in RPE65.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)#883898
- Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis#862437
- Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy#1172569
- Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65#894967
- Discovering a Novel AAV2-Based Capsid for RPE Transduction via Intravitreal Injection in rd12 Mice for Leber Congenital Amaurosis Type 2 Gene Therapy#634876
Record · ID 849647
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive